Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
IRB GOG0286B
CC 14-356
Hospital Fairview, Hillcrest, Main Campus
Stage Advanced/Metastatic, Stage 3, Stage 4A
Phase Phase 2, Phase 3
Disease Gynecologic
Drug Carboplatin, Metformin, Paclitaxel
